Surescripts shares promising results of a new technology that leveraged clinical intelligence and interoperability to streamline medication prior authorizations for GLP-1 drugs. Together with Optum and Cleveland Clinic, Surescripts realized greater workflow efficiency and faster approvals while maintaining essential clinical integrity, making it simpler to get patients started on the best treatment path without delay.
